Department of Biochemistry, Landmark University, Omu-Aran, Nigeria.
Department of Biochemistry, Ekiti State University, Ado-Ekiti, Nigeria.
PLoS One. 2022 Oct 27;17(10):e0276984. doi: 10.1371/journal.pone.0276984. eCollection 2022.
Annona muricata L. peel has been recognized for many ethnobotanical uses, including diabetes management. However, limited detailed scientific information about its mechanism of antidiabetic activity exists. The objective of this study was to evaluate the anti-diabetic properties of an aqueous extract of A. muricata peel (AEAMP) and its mechanism of action on alloxan-induced diabetic rats.
In vitro antidiabetic assays, such as α-amylase and α-glucosidase were analyzed on AEAMP. Alloxan monohydrate (150 mg/kg b.w) was used to induce diabetes in the rats. 150 mg/kg b.w positive control group doses of 6.67, 13.53, and 27.06 mg/kg were administered to 3 groups for twenty-one days. The positive control group was administered 30 mg/kg of metformin. The negative and normal control groups were administered distilled water. The fasting blood glucose, serum insulin, lipid profile, inflammatory cytokines, antioxidant markers, carbohydrate metabolizing enzymes, and liver glycogen were analyzed as well as PI3K/AKT and apoptotic markers PCNA and Bcl2 by RT-PCR.
AEAMP inhibited α-amylase and α-glucosidase enzymes more effectively than acarbose. AEAMP reduced FBG levels, HOMA-IR, G6P, F-1,6-BP, MDA, TG, TC, AI, CRI, IL-6, TNF-α, and NF-κB in diabetic rats. Furthermore, in diabetic rats, AEAMP improved serum insulin levels, HOMA-β, hexokinase, CAT, GST, and HDL-c. Liver PI3K, liver PCNA and pancreas PCNA were not significantly different in untreated diabetic rats when compared to normal rats suggesting alloxan induction of diabetes did not downregulate the mRNA expression of these genes. AEAMP significantly up-regulated expression of AKT and Bcl2 in the liver and pancreatic tissue. It is interesting that luteolin and resorcinol were among the constituents of AEAMP.
AEAMP can improve β-cell dysfunction by upregulating liver AKT and pancreatic PI3K and AKT genes, inhibiting carbohydrate metabolizing enzymes and preventing apoptosis by upregulating liver and pancreatic Bcl2. However, the potential limitation of this study is the unavailability of equipment and techniques for collecting more data for the study.
安农西亚木瓜果皮已被认可具有许多民族植物学用途,包括糖尿病管理。然而,关于其抗糖尿病活性的机制,目前仅有有限的详细科学信息。本研究的目的是评估安农西亚木瓜果皮水提物(AEAMP)的抗糖尿病特性及其对链脲佐菌素诱导的糖尿病大鼠的作用机制。
在体外进行抗糖尿病测定,如α-淀粉酶和α-葡萄糖苷酶,分析 AEAMP 的活性。用一水合链脲霉素(150mg/kg b.w)诱导大鼠糖尿病。将 150mg/kg b.w 的阳性对照剂量 6.67、13.53 和 27.06mg/kg 分别给予 3 组 21 天。阳性对照组给予 30mg/kg 二甲双胍。阴性和正常对照组给予蒸馏水。分析空腹血糖、血清胰岛素、血脂谱、炎症细胞因子、抗氧化标志物、糖代谢酶和肝糖原,以及通过 RT-PCR 分析 PI3K/AKT 和凋亡标志物 PCNA 和 Bcl2。
AEAMP 对α-淀粉酶和α-葡萄糖苷酶的抑制作用比阿卡波糖更有效。AEAMP 降低了糖尿病大鼠的 FBG 水平、HOMA-IR、G6P、F-1,6-BP、MDA、TG、TC、AI、CRI、IL-6、TNF-α和 NF-κB。此外,AEAMP 改善了糖尿病大鼠的血清胰岛素水平、HOMA-β、己糖激酶、CAT、GST 和 HDL-c。与正常大鼠相比,未经处理的糖尿病大鼠的肝 PI3K、肝 PCNA 和胰腺 PCNA 没有显著差异,提示链脲佐菌素诱导的糖尿病没有下调这些基因的 mRNA 表达。AEAMP 显著上调了肝和胰腺组织中 AKT 和 Bcl2 的表达。有趣的是,木犀草素和间苯二酚是 AEAMP 的成分之一。
AEAMP 可通过上调肝 AKT 和胰腺 PI3K 和 AKT 基因,抑制糖代谢酶并通过上调肝和胰腺 Bcl2 来预防细胞凋亡,从而改善β细胞功能障碍。然而,本研究的潜在局限性是缺乏设备和技术来收集更多的数据。